| Phase 3b, Open-label, Multicenter, Single-dose Study Investigating Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy Administered to Adult Subjects with Severe or Moderately Severe Hemophilia B with Detectable Pretreatment AAV5 Neutralizing Antibodies |
Ongoing |
HEMGENIX (etranacogene dezaparvovec) |
3b |
CSL222_3005 |
King Faisal Specialist Hospital and Research Center (Riyadh) |
| A Randomized, Double-blind, Placebo-controlled, Multicenter Study of a Single Dose of Inclacumab to Reduce Re-admission in Participants with Sickle Cell Disease and Recurrent Vaso-occlusive Crises |
Completed |
Inclacumab |
3 |
GBT2104-132 |
Prince Mohammad Bin Naser Hospital, Jizan, Saudi Arabi |
| A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants with Immunoglobulin A Nephropathy (IgAN) |
Ongoing |
Ravulizumab |
3 |
D928FC00001 |
King Faisal Specialist Hospital and Research Center (Riyadh),King Fahad Specialist Hospital (Dammam) |
| A Multicenter, Open-label, Single-arm, Phase 3 Long-Term Extension Study to Evaluate Continuous Safety and Efficacy of BIIB059 (Litifilimab) in Adult Participants with Active Subacute Cutaneous Lupus Erythematosus and/or Chronic Cutaneous Lupus Erythematosus with or without Systemic Manifestations and Refractory and/or Intolerant to Antimalarial Therapy (AMETHYST LTE) |
Ongoing |
Litifilimab |
3 |
230LE305 |
King Faisal Specialist Hospital and Research Center (Riyadh), King Khalid University Hospital (Riyadh) |
| REAL-WORLD, LONG-TERM DATA COLLECTION TO GAIN CLINICAL INSIGHTS INTO ROCHE OPHTHALMOLOGY PRODUCTS (VOYAGER STUDY)- COMPLETE |
Ongoing |
Vabysmo |
4 |
MR41927 |
King Abdulaziz Medical City NG (Jeddah) |
| SODium BICarbonate for Metabolic Acidosis in the Intensive Care Unit (SODa-BIC): A multicentre, randomised, double-blind clinical trial |
Ongoing |
SODIUM BICARBONATE |
3 |
SCT23R/012/10 |
King Abdulaziz Medical City NG (Riyadh) |
| Real-World Evidence Study for the Safety and Effectiveness of Ribociclib in Combination with Hormonal Therapy in Patients with HR+/HER2- Advanced or Metastatic Breast Cancer in the Middle East Region |
Ongoing |
Ribociclib |
4 |
CLEE011AIC |
King Faisal Specialist Hospital and Research Center (Riyadh) |
| The Effect of Empagliflozin (SGLT2 Inhibitor) in Pulmonary Arterial Hypertension: A Single Arm Prospective Interventional Study |
Ongoing |
Empagliflozin |
2 |
2231281 |
King Faisal Specialist Hospital and Research Center (Riyadh) |
| A multicenter real-world evidence study with retrospective chart review and cross-sectional survey to evaluate the satisfaction and benefits of long-term repeated BOTOX treatment for upper facial lines |
Ongoing |
Botox |
4 |
H24-500 |
Derma Clinic |
| Phase II, Prospective, Randomized, placebo-controlled, double-blind study.Evaluation of Phytochemical properties and Phytotherapeutic Potential of Boswellia carteri Birdw. in Psoriasis |
Ongoing |
boswellia carteri (Psorelia) |
2 |
E-23-7585 |
King Khalid University Hospital (Riyadh) |
